Synthetic MVA-based SARS-CoV-2 vaccine COH04S1

{
  "id": "MLC-T-ONC-016948",
  "term": "Synthetic MVA-based SARS-CoV-2 vaccine COH04S1",
  "field": "Oncology and biomedicine",
  "definition": "A vaccine comprised of a synthetic modified Vaccinia virus Ankara (sMVA) viral vector encoding the two severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) surface antigens spike (S) and nucleocapsid (N) proteins, with potential immunizing activity against SARS-CoV-2. Upon administration of the sMVA-based SARS-CoV-2 vaccine COH04S1, the SARS-CoV-2 S and N proteins are expressed in cells and presented to the immune system. This may activate both humoral and cellular immune responses which may result in protection against SARS-CoV-2 infection.",
  "synonyms": [
    "SARS-CoV-2 vaccine COH04S1",
    "sMVA-based SARS-CoV-2 vaccine COH04S1"
  ],
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/synthetic-mva-based-sars-cov-2-vaccine-coh04s1/"
}